Take-Two added to Wedbush's Best Ideas List on strong franchise moat, GTA VI potential
proactiveinvestors.com
Want to monitor ACET?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor ACETadicet bio, inc. is a privately held, pre-clinical stage biotechnology company engaged in the design and development of cutting-edge immunotherapies with initial focus on cancer. adicet is developing novel universal immune cell therapies based on gamma delta t cells engineered with chimeric antigen receptors (cars) or t cell receptors (tcrs).